725 related articles for article (PubMed ID: 30606129)
21. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the new risk prediction model (HCM Risk-SCD) and classic risk factors for sudden death in patients with hypertrophic cardiomyopathy and defibrillator.
Ruiz-Salas A; García-Pinilla JM; Cabrera-Bueno F; Fernández-Pastor J; Peña-Hernández J; Medina-Palomo C; Barrera-Cordero A; De Teresa E; Alzueta J
Europace; 2016 May; 18(5):773-7. PubMed ID: 25855675
[TBL] [Abstract][Full Text] [Related]
23. Refining the World Health Organization Definition: Predicting Autopsy-Defined Sudden Arrhythmic Deaths Among Presumed Sudden Cardiac Deaths in the POST SCD Study.
Tseng ZH; Salazar JW; Olgin JE; Ursell PC; Kim AS; Bedigian A; Probert J; Hart AP; Moffatt E; Vittinghoff E
Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007171. PubMed ID: 31248279
[TBL] [Abstract][Full Text] [Related]
24. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
[TBL] [Abstract][Full Text] [Related]
25. Clinical and prognostic impact of chronotropic incompetence in patients with hypertrophic cardiomyopathy.
Magri D; Agostoni P; Sinagra G; Re F; Correale M; Limongelli G; Zachara E; Mastromarino V; Santolamazza C; Casenghi M; Pacileo G; Valente F; Morosin M; Musumeci B; Pagannone E; Maruotti A; Uguccioni M; Volpe M; Autore C
Int J Cardiol; 2018 Nov; 271():125-131. PubMed ID: 30087038
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Implication of First-Degree Atrioventricular Block in Patients With Hypertrophic Cardiomyopathy.
Higuchi S; Minami Y; Shoda M; Shirotani S; Saito C; Haruki S; Gotou M; Yagishita D; Ejima K; Hagiwara N
J Am Heart Assoc; 2020 Mar; 9(6):e015064. PubMed ID: 32146896
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of Electrocardiographic Patterns at Presentation to Predict Long-term Risk of Cardiac Death in Patients With Hypertrophic Cardiomyopathy.
Biagini E; Pazzi C; Olivotto I; Musumeci B; Limongelli G; Boriani G; Pacileo G; Mastromarino V; Bacchi Reggiani ML; Lorenzini M; Lai F; Berardini A; Mingardi F; Rosmini S; Resciniti E; Borghi C; Autore C; Cecchi F; Rapezzi C
Am J Cardiol; 2016 Aug; 118(3):432-9. PubMed ID: 27289293
[TBL] [Abstract][Full Text] [Related]
28. Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated With Low Cardiovascular Mortality With Contemporary Management Strategies.
Maron BJ; Rowin EJ; Casey SA; Lesser JR; Garberich RF; McGriff DM; Maron MS
Circulation; 2016 Jan; 133(1):62-73. PubMed ID: 26518766
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Evaluation of Microvolt T-Wave Alternans in Hypertrophic Cardiomyopathy: 9-year Clinical Follow-up.
Antunes MO; Arteaga-Fernandez E; Samesima N; Pereira Filho HG; Matsumoto AY; Verrier RL; Pastore CA; Mady C
Arq Bras Cardiol; 2023; 120(8):e20220833. PubMed ID: 37672406
[TBL] [Abstract][Full Text] [Related]
30. Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
Sridharan A; Maron MS; Carrick RT; Madias CA; Huang D; Cooper C; Drummond J; Maron BJ; Rowin EJ
J Cardiovasc Electrophysiol; 2022 Jan; 33(1):20-29. PubMed ID: 34845799
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy.
Chan RH; Maron BJ; Olivotto I; Pencina MJ; Assenza GE; Haas T; Lesser JR; Gruner C; Crean AM; Rakowski H; Udelson JE; Rowin E; Lombardi M; Cecchi F; Tomberli B; Spirito P; Formisano F; Biagini E; Rapezzi C; De Cecco CN; Autore C; Cook EF; Hong SN; Gibson CM; Manning WJ; Appelbaum E; Maron MS
Circulation; 2014 Aug; 130(6):484-95. PubMed ID: 25092278
[TBL] [Abstract][Full Text] [Related]
32. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
[TBL] [Abstract][Full Text] [Related]
33. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
34. Impact of gender on heart failure presentation in non-obstructive hypertrophic cardiomyopathy.
Jang JH; Shin SH; Beak YS; Ko KY; Kwon SW; Park SD; Woo SI; Kim DH; Kwan J
Heart Vessels; 2020 Feb; 35(2):214-222. PubMed ID: 31482215
[TBL] [Abstract][Full Text] [Related]
35. Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation.
Zampieri M; Salvi S; Fumagalli C; Argirò A; Zocchi C; Del Franco A; Iannaccone G; Giovani S; Ferrantini C; Palinkas ED; Cappelli F; Olivotto I
Int J Cardiol; 2023 Mar; 374():65-72. PubMed ID: 36621577
[TBL] [Abstract][Full Text] [Related]
36. Relationship Between Genotype Status and Clinical Outcome in Hypertrophic Cardiomyopathy.
Bonaventura J; Rowin EJ; Chan RH; Chin MT; Puchnerova V; Polakova E; Macek M; Votypka P; Batorsky R; Perera G; Koethe B; Veselka J; Maron BJ; Maron MS
J Am Heart Assoc; 2024 May; 13(10):e033565. PubMed ID: 38757491
[TBL] [Abstract][Full Text] [Related]
37. Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.
Reant P; Mirabel M; Lloyd G; Peyrou J; Lopez Ayala JM; Dickie S; Bulluck H; Captur G; Rosmini S; Guttmann O; Demetrescu C; Pantazis A; Tome-Esteban M; Moon JC; Lafitte S; McKenna WJ
Heart; 2016 May; 102(10):741-7. PubMed ID: 26857213
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics and Long-Term Outcomes of Hypertrophic Cardiomyopathy.
Yoshinaga M; Yoshikawa D; Ishii H; Hirashiki A; Okumura T; Kubota A; Sakai S; Harada K; Somura F; Mizuno T; Fujiwara W; Yokoi H; Hayashi M; Ishii J; Ozaki Y; Murohara T; Yoshida Y; Amano T; Izawa H
Int Heart J; 2015; 56(4):415-20. PubMed ID: 26084460
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of patients with hypertrophic cardiomyopathy and low-normal left ventricular ejection fraction.
Choi YJ; Kim HK; Hwang IC; Park CS; Rhee TM; Lee HJ; Park JB; Yoon YE; Lee SP; Cho GY; Kim YJ
Heart; 2023 Apr; 109(10):771-778. PubMed ID: 36581445
[TBL] [Abstract][Full Text] [Related]
40. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
